UBS O'Connor’s HUTCHMED HCM Stock Holding History

UBS O'Connor’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-575,174	Closed	-$7.27M	–	976
2022 Q2	$7.27M	Buy	+575,174	New	+$7.32M	0.08%	161

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS O'Connor's HCM Position: Q3 2022 in Review

UBS O'Connor sold out of HUTCHMED (HCM) in Q3 2022, closing a stake of 575,174 shares — an estimated $7.27M sold.

UBS O'Connor first reported a position in HCM in Q2 2022 and held it in 1 quarter. The position peaked at $7.27M in Q2 2022. 107 funds tracked by Wall St. Rank hold HCM as of Q3 2022.

UBS O'Connor reported no remaining HUTCHMED position as of Q3 2022 after selling out during the quarter.
UBS O'Connor sold 575,174 HUTCHMED shares in Q3 2022, an estimated $7.27M.
UBS O'Connor first reported a position in HUTCHMED in Q2 2022 and held it in 1 quarter.
UBS O'Connor's HUTCHMED position peaked at $7.27M in Q2 2022.
107 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.